From professional translators, enterprises, web pages and freely available translation repositories.
pegaptanibi
pegaptanib
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
macugen pegaptanibi
macugen pegaptanib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikuttava aine on pegaptanibi.
the active substance is pegaptanib.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
macugen 0,3 mg injektioneste pegaptanibi
macugen 0.3 mg injection pegaptanib
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
macugenin vaikuttava aine pegaptanibi on aptameeri.
the active substance in macugen, pegaptanib, is an ‘aptamer’.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
macugen 0,3 mg injektioneste, liuos pegaptanibi
macugen 0.3 mg solution for injection pegaptanib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pegaptanibi metaboloituu endo- ja eksonukleaasien välityksellä.
pegaptanib is metabolised by endo- and exonucleases.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
silmään injektoituna pegaptanibi salpaa vegf:n toiminnan.
pegaptanib injected into the eye blocks vegf.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
eläimen lasiaiseen annettu pegaptanibi imeytyy silmästä hitaasti systeemiverenkiertoon.
in animals, pegaptanib is slowly absorbed into the systemic circulation from the eye after intravitreal administration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
imeytyminen eläimen lasiaiseen annettu pegaptanibi imeytyy silmästä hitaasti systeemiverenkiertoon.
absorption:in animals, pegaptanib is slowly absorbed into the systemic circulation from the eye after intravitreal administration.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
kanilla pegaptanibi eliminoituu kanta-aineena ja metaboliitteina ensisijaisesti virtsaan.
in rabbits, pegaptanib is eliminated as parent drug and metabolites primarily in the urine.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
lasiaiseen annettu pegaptanibi ei kerry plasmaan, kun antoväli on kuusi viikkoa.
pegaptanib does not accumulate in the plasma when administered intravitreally every 6 weeks.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
pegaptanibi metaboloituu nukleaasien välityksellä, ja siksi sytokromi p450 -välitteiset lääkeyhteisvaikutukset ovat epätodennäköisiä.
pegaptanib is metabolised by nucleases and therefore cytochrome p450 mediated drug interactions are unlikely.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
pegaptanibi on suunniteltu kiinnittymään proteiiniin nimeltä vaskulaarinen endoteelikasvutekijä (vegf) ja estämään sitä toimimasta.
pegaptanib has been designed to attach to and block a protein called vascular endothelial growth factor (vegf).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pegaptanibi- injektion jälkeen voi ilmetä verenvuotoja lasiaiseen heti (injektion antopäivänä) tai myöhemmin.
immediate (on the day of injection) and delayed intravitreous haemorrhages may occur following pegaptanib injections.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
hoitohyöty säilyi keskimäärin 102 viikkoa; näöntarkkuus säilyi potilailla, jotka uudelleensatunnaistettiin jatkamaan pegaptanibi-hoitoa.
on average, the treatment benefit was maintained at 102 weeks with continuing preservation of visual acuity for patients re-randomized to continue pegaptanib.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
niillä potilailla, jotka vuoden hoidon jälkeen uudelleensatunnaistettiin lopettamaan pegaptanibi-hoito, näöntarkkuus heikkeni toisen vuoden aikana.
patients who were re-randomized to discontinue pegaptanib after one year, lost visual acuity during the second year.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
laskimoon annettu pegaptanibi jakautuu hiirellä, rotalla, kanilla, koiralla ja apinalla ensisijaisesti plasmaan; se ei jakaudu laajalti perifeerisiin kudoksiin.
in mice, rats, rabbits, dogs and monkeys, pegaptanib distributes primarily into plasma volume and is not extensively distributed to peripheral tissues after intravenous administration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pegaptanibin markkinoille tulon jälkeen joissakin tapauksissa on havaittu anafylaksi / anafylaksia muistuttavia reaktioita, mukaan lukien angioedeemaa, useiden tuntien sisällä lasiaiseen annetusta pegaptanibi-injektiosta.
cases of anaphylaxis/anaphylactoid reactions, including angioedema, have been observed within several hours after the pegaptanib intravitreal administration procedure in the post-marketing experience.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
kun kanille annettiin lasiaiseen ja laskimoon radioaktiivisesti merkitty pegaptanibi-annos, suurimmat radioaktiivisuuspitoisuudet (lukuun ottamatta silmää, jonka lasiaiseen annos injisoitiin) todettiin munuaisissa.
after intravitreal and intravenous administrations of radiolabeled pegaptanib to rabbits, the highest concentrations of radioactivity (excluding the eye for the intravitreal dose) were obtained in the kidney.
Last Update: 2017-04-26
Usage Frequency: 4
Quality: